Doctors are speaking out to quash rumors that the COVID-19 vaccine affects fertility.The myth is "wholesale nonsense," according to Prof Van-Tam, England s
Getty/Matthew Horwood
The myth is wholesale nonsense, according to Prof Van-Tam, England s deputy chief medical officer.
Medics have come together on social media to reinforce the message.
Doctors are speaking out to reassure the public that receiving one of the COVID-19 vaccines will not affect fertility.
After dangerous rumors started swirling on social media that getting vaccinated against the coronavirus could hamper male and female fertility, medics and health experts have confirmed that this is a myth.
Dr Edward Morris, President at the Royal College of Obstetricians and Gynecologists, said in a statement: We want to reassure women that there is no evidence to suggest that COVID-19 vaccines will affect fertility. Claims of any effect of COVID-19 vaccination on fertility are speculative and not supported by any data.
The COVID Vaccine: A Shot in the Arm for Fertility Treatment?
Appeared in BioNews 1082
The rollout of COVID vaccination programmes has brought with it a renewed hope of a return to normality but has also raised questions about the impact of vaccination on fertility treatment and pregnancy.
To help explain and clarify the advice to fertility patients and clinicians, and to fight misinformation spreading online, the Progress Educational Trust (PET) – the charity that publishes BioNew – held an online event. The COVID-19 Vaccine: A Shot in the Arm for Fertility Treatment? was chaired by PET s director Sarah Norcross, and featured speakers outlining the approaches taken by UK, EU and US bodies.
An All-Consuming Problem? How to Protect Patients in the Fertility Market
Appeared in BioNews 1079
The UK Government s Competition and Markets Authority (CMA) has drafted consumer law guidance for fertility clinics, due to come into effect in the spring of 2021. The purpose of the guidance is to help providers of fertility treatment in the UK to understand and comply with their obligations under consumer law. The CMA is seeking responses to the draft guidance from interested parties. This is an important development, given that the majority of fertility treatment in the UK remains self-funded.
PET invited a panel representing regulators, clinicians and patients to give their assessment of the draft guidance as well as to discuss its role and potential effects. After a brief introduction, PET s director Sarah Norcross got right to the heart of the matter by asking the panel: are those who seek self-funded IVF treatment patients or consumers?